Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AtLaS: Simplification to atazanavir/ritonavir + lamivudine in virologically suppressed HIV patients
2009-011273-32Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atazanavir, ritonavir and lamivudine in human immunodeficiency virus infection (HIV), sponsored by Policlinico Gemelli. Primary endpoint: Virological failure within 48 weeks (intention-to-treat). Started Apr 2009; status: completed.
02
Drugs
atazanavirritonavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-011273-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011273-32.